Arcturus Therapeutics (NASDAQ: ARCT) is gearing up to announce its quarterly earnings on Tuesday, 2026-03-03. Here's a quick ...

Halozyme Therapeutics, Inc. ("Halozyme" or the "Company") today reported its financial and operating results for the full ...

Arcturus Therapeutics now centers on ARCT-032 (cystic fibrosis) and ARCT-810 (OTC deficiency), with Covid assets as secondary cash support. ARCT is priced as a busted biotech with optionality; cash ...

One of the most exciting events in the winter Olympics is ice hockey. This is likely because it is the sport that fans see more often throughout the year and are most familiar with. It is also the ...

We recently published an article titled 11 High Growth Micro-cap Stocks to Buy. On January 6, Citi lowered its price target on Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) to $7 from $9 while ...

What fits in the overhead bin today may not tomorrow, according to a warning that has travelers rethinking how much confidence they can place in carry-on labels. In the clip, Schaler said that, “so ...

We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. The seventeenth stock on our list is Arcturus Therapeutics Holdings Inc. TheFly reported on January 22 that Roth Capital ...